A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma
Condition(s):Carcinoma, ThymicLast Updated:March 15, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Carcinoma, ThymicLast Updated:March 15, 2024Active, not recruiting
Condition(s):Thymic Epithelial Tumor; Recurrent Thymoma; Thymic CancerLast Updated:January 12, 2024Recruiting
Condition(s):Thymoma; Thymic CarcinomaLast Updated:February 22, 2024Not yet recruiting
Condition(s):Thymoma; Thymic CarcinomaLast Updated:April 12, 2013Terminated
Condition(s):Thymoma; Thymic CarcinomaLast Updated:September 30, 2015Completed
Condition(s):Thymoma; Thymic CarcinomaLast Updated:June 29, 2023Completed
Condition(s):Thymic CarcinomaLast Updated:March 15, 2024Suspended
Condition(s):Thymoma and Thymic CarcinomaLast Updated:February 7, 2020Completed
Condition(s):Thymic CarcinomaLast Updated:September 6, 2023Recruiting
Condition(s):Thymoma; Advanced Thymic Epithelial TumourLast Updated:March 15, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.